triiodothyronine has been researched along with Cardiovascular Pregnancy Complications in 5 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Excerpt | Relevance | Reference |
---|---|---|
"Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
"Following the diagnosis of fetal goitre at 22 and 24 weeks' gestation in two hyperthyroid pregnant women who underwent treatment with 400-500 mg of propylthiouracil in the first weeks of pregnancy, a total of seven fetal blood samplings were performed to evaluate thyroid function before and after the initiation of two different treatment regimens." | 3.69 | Prenatal treatment of fetal hypothyroidism: is there more than one option? ( Acaia, B; Beck-Peccoz, P; Cortelazzi, D; Nicolini, U; Venegoni, E, 1996) |
"Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bańkowska, EM | 1 |
Pawłowska, A | 1 |
Leibschang, J | 1 |
Schreyer, P | 1 |
Caspi, E | 1 |
Letko, Y | 1 |
Ron-El, R | 1 |
Pinto, N | 1 |
Ziedman, JL | 1 |
Nicolini, U | 1 |
Venegoni, E | 1 |
Acaia, B | 1 |
Cortelazzi, D | 1 |
Beck-Peccoz, P | 1 |
Valensise, H | 1 |
Civitella, C | 1 |
Garzetti, GG | 1 |
Romanini, C | 1 |
Felt, V | 1 |
5 other studies available for triiodothyronine and Cardiovascular Pregnancy Complications
Article | Year |
---|---|
[Thyroid function in pregnant women with pregnancy induced hypertension].
Topics: Adult; Female; Humans; Hypertension; Hyperthyroidism; Pregnancy; Pregnancy Complications, Cardiovasc | 2003 |
Intraamniotic triidothyronine instillation for prevention of respiratory distress syndrome in pregnancies complicated by hypertension.
Topics: Adult; Amnion; Amniotic Fluid; Female; Fetal Blood; Humans; Hypertension; Infant, Newborn; Injection | 1982 |
Prenatal treatment of fetal hypothyroidism: is there more than one option?
Topics: Adult; Amniotic Fluid; Female; Fetal Blood; Gestational Age; Humans; Hyperthyroidism; Hypothyroidism | 1996 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
Thyroid and steroid hormones and metabolic parameters in myocardial infarction.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Blood Glucose; Female; Glucocorticoids; Humans; L | 1969 |